FAK Inhibitor in Patients With Advanced Solid Tumors
Clinical trial NCT07596381 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07596381
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2027-02-28
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.